ADMA Biologics's market cap is currently $3.80B. The company's EPS TTM is $0.276; its P/E ratio is 57.33; ADMA Biologics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 258.21M	$ 154.08M	$ 80.94M	$ 42.22M	$ 29.35M
Gross Profit	$ 88.94M	$ 35.27M	$ 1.17M	$ -19.07M	$ -10.16M
Operating Income	$ 21.63M	$ -39.37M	$ -58.37M	$ -64.91M	$ -41.42M
EBITDA	$ 5.12M	$ -39.72M	$ -53.33M	$ -59.82M	$ -36.03M
Net Income	$ -28.24M	$ -85.18M	$ -84.45M	$ -87.61M	$ -57.05M
Balance Sheet
Cash & Short-Term Investments	$ 51.35M	$ 86.52M	$ 51.09M	$ 55.92M	$ 26.75M
Total Assets	$ 329.18M	$ 348.46M	$ 276.25M	$ 207.67M	$ 127.09M
Total Debt	$ 141.42M	$ 154.44M	$ 102.92M	$ 97.67M	$ 84.73M
Net Debt	$ 90.07M	$ 67.92M	$ 51.83M	$ 41.75M	$ 57.98M
Total Liabilities	$ 193.98M	$ 196.49M	$ 135.08M	$ 119.42M	$ 100.90M
Stockholders' Equity	$ 135.21M	$ 151.97M	$ 141.17M	$ 88.25M	$ 26.19M
Cash Flow
Free Cash Flow	$ 3.82M	$ -73.42M	$ -125.88M	$ -114.73M	$ -80.01M
Operating Cash Flow	$ 8.80M	$ -59.51M	$ -112.37M	$ -102.00M	$ -76.19M
Investing Cash Flow	$ -4.98M	$ -13.91M	$ -13.51M	$ -12.72M	$ -3.81M
Financing Cash Flow	$ -38.99M	$ 108.85M	$ 121.05M	$ 143.90M	$ 80.00M

Currency in USD

ADMA Biologics Earnings and Revenue History

Income Statement >

ADMA Biologics Debt to Assets

Balance Sheet >

ADMA Biologics Cash Flow

Cash Flow >

ADMA Biologics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing